Advertisement

Clinical Utility of Inflammatory Markers & Advanced Lipoprotein Testing: Advice from Lipid Specialists

Last Updated:
Publish Date: 
October 4, 2011 - 12:00pm

The NLA held a consensus conference in January 2011 to bring together experts on inflammatory markers and advanced lipoprotein testing for the generation of an NLA statement of clinical guidance regarding the utility of various biomarkers. The panel reviewed apolipoprotein B (Apo B), C-reactive protein (CRP), high-density lipoprotein (HDL) subfractions, lipoprotein-associated phospholipase A2 (Lp-PLA2), low-density lipoprotein (LDL) subfractions, low-density lipoprotein particle number/concentration (LDL-P), and lipoprotein (a) (Lp(a)). The link above provides the statement of NLA expert panel, published in the October 2011 edition of the Journal of Clinical Lipidology.

Copyright © 2018 National Lipid Association. All Rights Reserved.

Privacy Policy Terms of Service